Vendor, San Rafael, CA
Aso Therapeutics, Inc.
UEI K8R9YHMX6Q31, CAGE 06A12
1 award and -$55,000 obligated between September 11, 2026 and September 11, 2026, 100% under full and open competition, against 55.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$55,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00011Definitive Contract, September 11, 2026, Full and Open Competition After Exclusion of Sources, 55 offers | NIH NCINational Institutes of Health | EO14398 FY2025 SBIR Concept Clearance Award or Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of NAICS 541715, PSC AN11 | -$55,000 |
- Places of performance
- California
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards